Cargando…

(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma

INTRODUCTION: Paclitaxel (Taxol(®)) is a microtubule-targeted agent that is widely used for cancer treatment. However, resistance to paclitaxel is frequently encountered in the clinic. There is increasing interest in identifying compounds that may increase the sensitivity to conventional chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ting, Wang, Jiao, Yin, Yancun, Hua, Hui, Jing, Jing, Sun, Xiangming, Li, Minjing, Zhang, You, Jiang, Yangfu
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880428/ https://www.ncbi.nlm.nih.gov/pubmed/20078855 http://dx.doi.org/10.1186/bcr2473

Ejemplares similares

Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response
por: Wang, Jiao, et al.
Publicado: (2009)

The anticancer flavonoid chrysin induces the unfolded protein response in hepatoma cells
por: Sun, Xiangming, et al.
Publicado: (2011)

Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70
por: Li, Minjing, et al.
Publicado: (2009)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

The regulation of steroid receptors by epigallocatechin-3-gallate in breast cancer cells
por: Hallman, Kelly, et al.
Publicado: (2017)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells
por: Park, Sunghoon, et al.
Publicado: (2014)

Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
por: Zhang, Qiang, et al.
Publicado: (2023)

Bioaccessibility and Bioavailability of (-)-Epigallocatechin Gallate in the Bread Matrix with Glycemic Reduction
por: Li, Lanqi, et al.
Publicado: (2022)

Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells
por: Mineva, Nora D., et al.
Publicado: (2013)

Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines
por: Farabegoli, Fulvia, et al.
Publicado: (2022)

Role of epigallocatechin-3- gallate in the regulation of known and novel microRNAs in breast carcinoma cells
por: Banerjee, Shrila, et al.
Publicado: (2022)

AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin
por: Gao, Mei, et al.
Publicado: (2016)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Enhancement of Cisplatin Sensitivity in Human Cervical Cancer: Epigallocatechin-3-Gallate
por: Kilic, Ulkan, et al.
Publicado: (2015)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Protective effects of (-)-epigallocatechin gallate on UVA-induced damage in ARPE19 cells
por: Chan, Chi-Ming, et al.
Publicado: (2008)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
por: Zhang, Xin, et al.
Publicado: (2016)

Epigallocatechin-3-Gallate Reduces Cytotoxic Effects Caused by Dental Monomers: A Hypothesis
por: Jiao, Yang, et al.
Publicado: (2015)

Protective effects of (-)-epigallocatechin-3-gallate against acetaminophen-induced liver injury in rats)
por: Yao, Hsien-Tsung, et al.
Publicado: (2015)

Effects of Physiological Levels of the Green Tea Extract Epigallocatechin-3-Gallate on Breast Cancer Cells
por: Zeng, Li, et al.
Publicado: (2014)

EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion
por: Farabegoli, Fulvia, et al.
Publicado: (2017)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Potential of Cucurbitacin B and Epigallocatechin Gallate as Biopesticides against Aphis gossypii
por: Zhao, Chenchen, et al.
Publicado: (2021)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

Attenuation of muscle wasting in murine C(2)C(12) myotubes by epigallocatechin-3-gallate
por: Mirza, Kamran A., et al.
Publicado: (2014)

The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes
por: Chu, Yu-Wen, et al.
Publicado: (2017)

Reducing the potential allergenicity of amandin through binding to (−)-epigallocatechin gallate
por: Luo, Xin, et al.
Publicado: (2022)

The Effect of (−)-Epigallocatechin-3-Gallate Non-Covalent Interaction with the Glycosylated Protein on the Emulsion Property
por: Feng, Haiying, et al.
Publicado: (2019)

Epigallocatechin-3-gallate enhances the osteoblastogenic differentiation of human adipose-derived stem cells
por: Zhang, Jing, et al.
Publicado: (2019)

A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
por: Scandlyn, M J, et al.
Publicado: (2008)

Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25
por: Zan, Lingling, et al.
Publicado: (2019)

Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release
por: Cao, Yizheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2brt63n71f2matqu6m7t04ld24